Gedatolisib, Hydroxychloroquine or the Combination for Prevention of Recurrent Breast Cancer ("GLACIER")

NCT03400254 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped due to business decision regarding the study drug.

Conditions

Interventions

Sponsor

Abramson Cancer Center at Penn Medicine

Collaborators